This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Mikael Eriksson (scientist) | |
|---|---|
| Name | Mikael Eriksson |
| Birth date | 1950s |
| Birth place | Uppsala, Sweden |
| Fields | Biology, Biochemistry, Molecular Biology |
| Workplaces | Uppsala University, Karolinska Institutet, Max Planck Society |
| Alma mater | Uppsala University, Karolinska Institutet |
| Known for | Protein folding, Chaperone systems, Molecular dynamics |
Mikael Eriksson (scientist) is a Swedish biochemist and molecular biologist noted for contributions to protein folding, molecular chaperones, and computational modeling of biomolecular dynamics. His work spans experimental biophysics, cryo-electron microscopy collaborations, and theoretical frameworks linking thermodynamics with cellular proteostasis. Eriksson established influential laboratories and collaborated with major European research institutions across genetics and structural biology.
Eriksson was born in Uppsala and educated at Uppsala University, where he studied under mentors affiliated with Karolinska Institutet and the Royal Institute of Technology. He completed a doctoral thesis that integrated methods from X-ray crystallography, nuclear magnetic resonance spectroscopy, and physical chemistry, drawing influence from researchers at the Max Planck Society, ETH Zurich, and University of Cambridge. Postdoctoral training included stints at laboratories connected to Cold Spring Harbor Laboratory, Massachusetts Institute of Technology, and collaborations with groups at University of California, San Francisco.
Eriksson established his first independent group at Uppsala University and later directed a center affiliated with Karolinska Institutet and the Swedish Research Council. His laboratories combined techniques from cryo-electron microscopy, single-molecule fluorescence microscopy, and computational approaches developed alongside teams at European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, and CERN-adjacent computing consortia. He collaborated with investigators from Harvard University, Princeton University, Yale University, University of Oxford, and industry partners such as Novo Nordisk and AstraZeneca. Funding came from agencies including the European Research Council, Human Frontier Science Program, and national bodies like the Knights of the Order of the Polar Star-adjacent cultural grants (granting structures paralleling those supporting Swedish science).
Eriksson advanced models of protein folding landscapes building on the theoretical lineage of Linus Pauling, Christian Anfinsen, and John Kendrew, proposing testable hypotheses relating chaperone cycles to cellular stress responses studied by groups at National Institutes of Health and Pasteur Institute. He characterized novel Hsp70-family interactions and cross-talk with proteostasis networks studied at Broad Institute and introduced kinetic models inspired by work at Bell Labs and Salk Institute. Eriksson's theoretical contributions integrated ideas from Alan Turing-inspired pattern formation, Ilya Prigogine's nonequilibrium thermodynamics, and statistical mechanics traditions at Princeton Plasma Physics Laboratory to explain misfolding pathways implicated in studies at Mayo Clinic and Columbia University on amyloid diseases.
Eriksson authored landmark papers in journals associated with Nature Publishing Group, Cell Press, and Proceedings of the National Academy of Sciences. Selected works include empirical studies using datasets coordinated with European Bioinformatics Institute, structural reports in collaboration with Max Planck Institute for Biophysical Chemistry, and review articles synthesizing perspectives from Science Magazine and Annual Reviews. He contributed chapters to volumes edited by scholars from University of Chicago Press and participated in proceedings alongside researchers from Royal Society symposia and Gordon Research Conferences.
Eriksson received recognition from institutions including honorary fellowships at Royal Society of Edinburgh-affiliated exchanges, prizes sponsored by the Royal Swedish Academy of Sciences, and membership invitations from academies such as the European Academy of Sciences and Arts. He was awarded grants and medals reminiscent of honors given by Lund University-linked societies and received visiting professorships funded through programs with Alexander von Humboldt Foundation and Fulbright Program-affiliated exchanges.
Eriksson held professorships at Uppsala University and visiting chairs at Karolinska Institutet, with sabbaticals at Max Planck Institute for Molecular Genetics and the European Molecular Biology Laboratory. He served on advisory boards for European Research Council panels, editorial boards for journals published by Oxford University Press and Springer Nature, and participated in consortia with Institut Pasteur, Institut Curie, and Wellcome Trust-funded networks. His trainees went on to positions at Stanford University, Imperial College London, Johns Hopkins University, and national research institutes.
Eriksson's integration of experimental biophysics and computational theory influenced subsequent generations working at intersections exemplified by labs at Cold Spring Harbor Laboratory, Max Planck Society, and European Molecular Biology Laboratory. His models informed therapeutic strategies explored by researchers at University of Pennsylvania and biopharmaceutical collaborations with Pfizer and GlaxoSmithKline. Eriksson's emphasis on interdisciplinary training fostered links among Uppsala University, Karolinska Institutet, ETH Zurich, and transatlantic partners, leaving a durable imprint on studies of proteostasis, structural enzymology, and the molecular basis of neurodegenerative disease.
Category:Swedish biochemists Category:Structural biologists